{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:38:18Z","timestamp":1794451098080,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.eururo.2017.05.055","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T05:30:17Z","timestamp":1497159017000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-4026","authenticated-orcid":false,"given":"Christopher J.D.","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Huland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.05.055_bib0535","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MOU.0000000000000157","article-title":"Observational studies and the natural history of screen-detected prostate cancer","volume":"25","author":"Albertsen","year":"2015","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib1065","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0545","series-title":"Initial national priorities for comparative effectiveness research","author":"Institute of Medicine","year":"2009"},{"key":"10.1016\/j.eururo.2017.05.055_bib0550","series-title":"Guidance for industry. Clinical trial endpoints for the approval of cancer drugs and biologics","author":"Food and Drug Administration","year":"2007"},{"key":"10.1016\/j.eururo.2017.05.055_bib0555","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/jnci\/93.23.1822","article-title":"Determining cause of death in prostate cancer: are death certificates valid?","volume":"93","author":"Penson","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2017.05.055_bib0560","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0565","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1470-2045(11)70295-9","article-title":"Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials","volume":"13","author":"D\u2019Amico","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0570","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.3747\/co.21.1865","article-title":"Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events","volume":"21","author":"Krahn","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0575","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/bjc.2015.54","article-title":"Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer","volume":"112","author":"Wallis","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib0580","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","article-title":"Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence","volume":"59","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0585","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0590","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urology.2007.10.053","article-title":"Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion\u2014\u201cnadir+2\u201d?","volume":"72","author":"Nielsen","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.05.055_bib0595","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2014.09.017","article-title":"Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence","volume":"67","author":"Lee","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0600","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0605","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0610","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-5347(17)53016-5","article-title":"Radical surgery versus radiotherapy for adenocarcinoma of the prostate","volume":"128","author":"Paulson","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0615","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0620","unstructured":"Wallis CJ, Nam RK. The optimal treatment of patients with localized prostate cancer: the debate rages on. www.bjuinternational.com\/bjui-blog\/the-optimal-treatment-of-patients-with-localized-prostate-cancer-the-debate-rages-on."},{"key":"10.1016\/j.eururo.2017.05.055_bib0625","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bju.13734","article-title":"\u201cProtecTion\u201d from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?","volume":"119","author":"Wang","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0630","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S1470-2045(14)70198-6","article-title":"The ProtecT trial: what can we expect?","volume":"15","author":"Roobol","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0635","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/0284186X.2014.974827","article-title":"Radical prostatectomy versus high-dose irradiation in localized\/locally advanced prostate cancer: a Swedish multicenter randomized trial with patient-reported outcomes","volume":"54","author":"Lennernas","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0640","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery versus radiotherapy for clinically localized prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0645","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/dji248","article-title":"Prostate cancer and the Will Rogers phenomenon","volume":"97","author":"Albertsen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2017.05.055_bib0650","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.urolonc.2016.03.021","article-title":"The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer","volume":"35","author":"Tyson","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0655","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2015.08.005","article-title":"Radical prostatectomy versus radiation and androgen deprivation therapy for clinically localized prostate cancer: how good is the evidence?","volume":"93","author":"Roach","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2017.05.055_bib0660","unstructured":"Reeves BC, Deeks JJ, Higgins JP, Wells GA. Tools for assessing methodological quality of risk of bias in non-randomized studies. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.02011."},{"key":"10.1016\/j.eururo.2017.05.055_bib0665","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2017.05.055_bib0670","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bju.12321","article-title":"Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation","volume":"113","author":"Sun","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0675","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jama.297.3.278","article-title":"Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods","volume":"297","author":"Stukel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0680","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/cncr.23452","article-title":"Limits of observational data in determining outcomes from cancer therapy","volume":"112","author":"Giordano","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib0685","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1002\/cncr.25456","article-title":"Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer","volume":"116","author":"Cooperberg","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib0690","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2009.22.2265","article-title":"Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix","volume":"28","author":"Zelefsky","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0695","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2016.06.046","article-title":"Clinical outcomes for patients with Gleason score 9-10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis","volume":"71","author":"Kishan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0700","unstructured":"Phillips B, Ball C, Sackett DL, et al. Oxford Centre for Evidence-based Medicine\u2014levels of evidence (March 2009). www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009."},{"key":"10.1016\/j.eururo.2017.05.055_bib0705","first-page":"409","article-title":"Basic methods for the assessment of the health related quality of life in uro-oncological patients","volume":"69","author":"Sosnowski","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0710","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0715","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00345-009-0418-9","article-title":"Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study","volume":"27","author":"Giberti","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0720","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/NCC.0b013e3182567c03","article-title":"Partners\u2019 long-term appraisal of their caregiving experience, marital satisfaction, sexual satisfaction, and quality of life 2 years after prostate cancer treatment","volume":"36","author":"Harden","year":"2013","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.eururo.2017.05.055_bib0725","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa021483","article-title":"Quality of life after radical prostatectomy or watchful waiting","volume":"347","author":"Steineck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0730","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0735","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2003.01.199","article-title":"Time course and predictors of symptoms after primary prostate cancer therapy","volume":"21","author":"Talcott","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0740","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0745","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0750","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0755","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bju.13499","article-title":"Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review","volume":"118","author":"Whiting","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0760","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","article-title":"Defining a standard set of patient-centered outcomes for men with localized prostate cancer","volume":"67","author":"Martin","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0765","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","article-title":"Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study","volume":"15","author":"Nam","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0770","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.urology.2014.11.037","article-title":"Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis","volume":"85","author":"Wallis","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.05.055_bib0775","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.eururo.2015.10.043","article-title":"New rates of interventions to manage complications of modern prostate cancer treatment in older men","volume":"69","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0780","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2016.05.054","article-title":"Hospitalizations to manage complications of modern prostate cancer treatment in older men","volume":"96","author":"Wallis","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.05.055_bib0785","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bju.13647","article-title":"Risk of hospitalisation after primary treatment for prostate cancer","volume":"120","author":"Williams","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0790","first-page":"106","article-title":"Pathological effects of ionizing radiation","volume":"4","author":"Sheaff","year":"1997","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0795","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2011.10864.x","article-title":"Posterior urethral complications of the treatment of prostate cancer","volume":"110","author":"Mundy","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0800","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.juro.2016.10.091","article-title":"Urinary diversion for severe urinary adverse events of prostate radiation: results from a multi-institutional study","volume":"197","author":"Bassett","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0805","doi-asserted-by":"crossref","first-page":"i851","DOI":"10.1136\/bmj.i851","article-title":"Secondary malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2017.05.055_bib0810","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0815","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.294.20.2587","article-title":"Risk of pelvic fractures in older women following pelvic irradiation","volume":"294","author":"Baxter","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0820","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21037\/apm.2016.05.01","article-title":"Pelvic insufficiency fractures in women following radiation treatment: a case series","volume":"5","author":"Chan","year":"2016","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0825","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.urology.2016.08.002","article-title":"Cardiovascular and skeletal-related events following localised prostate cancer treatment: role of surgery, radiotherapy and androgen-deprivation","volume":"97","author":"Wallis","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.05.055_bib0830","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.ejca.2012.01.035","article-title":"Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden","volume":"48","author":"Thorstenson","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib0835","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0840","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2014long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2017.05.055_bib0845","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.299.3.289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D\u2019Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0850","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.05.055_bib0855","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2014.58.0662","article-title":"Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation Therapy Oncology Group randomized clinical trial 9910","volume":"33","author":"Pisansky","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.eururo.2017.05.055_bib0860","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bju.12964","article-title":"Adverse effects of androgen-deprivation therapy in prostate cancer and their management","volume":"115","author":"Rhee","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.05.055_bib0865","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1200\/JCO.2012.41.8509","article-title":"Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer","volume":"30","author":"Higano","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0870","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.juro.2006.08.113","article-title":"Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer","volume":"177","author":"Haliloglu","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0875","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-5347(17)43497-5","article-title":"Effect of treatment with chronic gonadotropin releasing hormone agonist on human testis","volume":"138","author":"Hadziselimovic","year":"1987","journal-title":"J Urol"},{"issue":"7 Suppl","key":"10.1016\/j.eururo.2017.05.055_bib0880","first-page":"S86","article-title":"The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis","volume":"190","author":"Couper","year":"2009","journal-title":"Med J Austral"},{"key":"10.1016\/j.eururo.2017.05.055_bib0885","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2016.06.2445","article-title":"Late radiation and cardiovascular adverse effects after androgen deprivation and high-dose radiation therapy in prostate cancer: results from the DART 01\/05 randomized phase 3 trial","volume":"96","author":"Zapatero","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2017.05.055_bib0890","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2017.05.055_bib0895","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.urolonc.2012.04.008","article-title":"Health-related quality of life for men with prostate cancer\u2014an evaluation of outcomes 12-24 months after treatment","volume":"31","author":"Brassell","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0900","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.eururo.2016.11.015","article-title":"Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy","volume":"71","author":"Adam","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0905","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.urology.2013.06.062","article-title":"Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality\/hormonal and sexual quality of life: results of a multicenter prospective study","volume":"82","author":"Gay","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.05.055_bib0910","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(16)30592-X","article-title":"Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study","volume":"388","author":"Yaxley","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2017.05.055_bib0915","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.eururo.2014.02.015","article-title":"Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control","volume":"66","author":"Hu","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0920","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.juro.2016.01.105","article-title":"Comparison of perioperative and early oncologic outcomes between open and robotic assisted laparoscopic prostatectomy in a contemporary population based cohort","volume":"196","author":"Pearce","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0925","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.juro.2016.09.115","article-title":"Comparative effectiveness of cancer control and survival after robot-assisted versus open radical prostatectomy","volume":"197","author":"Hu","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0930","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.juro.2015.08.092","article-title":"The comparative harms of open and robotic prostatectomy in population based samples","volume":"195","author":"O\u2019Neil","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0935","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.2011.36.8621","article-title":"Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men","volume":"30","author":"Barry","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0940","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1097\/01.ju.0000091100.83725.51","article-title":"Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens","volume":"170","author":"Eastham","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0945","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2003.05.169","article-title":"Role of surgeon volume in radical prostatectomy outcomes","volume":"21","author":"Hu","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0950","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5489\/cuaj.3214","article-title":"Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohort","volume":"10","author":"Almatar","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2017.05.055_bib0955","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2015.07.037","article-title":"Nerve-sparing surgery technique, not the preservation of the neurovascular bundles, leads to improved long-term continence rates after radical prostatectomy","volume":"69","author":"Michl","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0960","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2012.04.057","article-title":"Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients","volume":"62","author":"Schlomm","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0965","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2010.31.1217","article-title":"Cost implications of the rapid adoption of newer technologies for treating prostate cancer","volume":"29","author":"Nguyen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0970","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2016.06.006","article-title":"Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer","volume":"48","author":"Zaorsky","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.eururo.2017.05.055_bib0975","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2017.05.055_bib0980","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijrobp.2010.01.006","article-title":"Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?","volume":"79","author":"Kuban","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7 Suppl","key":"10.1016\/j.eururo.2017.05.055_bib0985","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/jco.2015.33.7_suppl.4","article-title":"A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer","volume":"33","author":"Michalski","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0990","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib0995","doi-asserted-by":"crossref","unstructured":"Zaorsky NG, Keith SW, Shaikh T, et al. Impact of radiation therapy dose escalation on prostate cancer outcomes and toxicities. Am J Clin Oncol, e-published 2016 Mar 24. In press. http:\/\/dx.doi.org\/10.1097\/COC.0000000000000285.","DOI":"10.1097\/COC.0000000000000285"},{"key":"10.1016\/j.eururo.2017.05.055_bib1000","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2017.05.055_bib1005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib1010","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(16)30070-5","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Incrocci","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib1015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13566-015-0237-0","article-title":"Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer","volume":"5","author":"Oliai","year":"2016","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib1020","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/cncr.30101","article-title":"Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer","volume":"122","author":"Halpern","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib1025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2013.53.8652","article-title":"Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity","volume":"32","author":"Yu","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.05.055_bib1030","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.28536","article-title":"Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer","volume":"120","author":"Hoppe","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib1035","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/cncr.28697","article-title":"The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base","volume":"120","author":"Martin","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.05.055_bib1040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2013.08.005","article-title":"Declining use of brachytherapy for the treatment of prostate cancer","volume":"13","author":"Mahmood","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2017.05.055_bib1045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.brachy.2016.05.001","article-title":"The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness","volume":"15","author":"Orio","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2017.05.055_bib1050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","article-title":"*ASCENDE-RT: An analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"10.1016\/j.eururo.2017.05.055_bib1055","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ijrobp.2015.07.289","article-title":"Toxicity outcomes in ASCENDE-RT: a multicenter randomized trial of dose-escalation trial for prostate cancer","volume":"93","author":"Rodda","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"10.1016\/j.eururo.2017.05.055_bib1060","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2015.07.012","article-title":"Quality of life outcomes: ASCENDE-RT a multicenter randomized trial of radiation therapy for prostate cancer","volume":"93","author":"Rodda","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817304955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817304955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:50:50Z","timestamp":1535745050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817304955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0302283817304955"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.05.055","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.05.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}